All Stories

  1. Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discovery
  2. Recent Advances in Pharmacoeconomics and Pharmacogenomics: Evaluating Cost-Effectiveness in Personalized Medicine
  3. Plant-derived exosomes as next-generation biomaterials: emerging therapeutic platforms for cancer and gut disorders
  4. Nanoliposomes based drug delivery for the treatment of various types of cancers: current trends and future perspectives
  5. Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review
  6. Synthesis, in vitro anti-HIV-1 reverse transcriptase evaluation, molecular modelling, DFT analysis and acute oral toxicity assessment of benzotriazole derivatives
  7. Drug repurposing against viral infections (2020–2025): clinical trials, computational strategies, and therapeutic interventions
  8. Geographic and botanical determinants of propolis: variability in chemical constituents and antimicrobial effects
  9. Rational drug design and synthesis of novel bioactive molecules with oxygen heterocycles, including AChE and BChE inhibitory properties and SAR studies
  10. Phytoprotective Effects of Limonia acidissima Linn against Crystalline Damage: Examining the Renal Protective Role in Ethylene Glycol-Induced Urolithiasis in Rats
  11. Therapeutic potential of nitrogen-containing heterocyclic compounds in Alzheimer's disease: From molecular design to SAR studies
  12. The molecular landscape of kidney stone disease: pathophysiology to personalized intervention
  13. Computationally guided synthesis and biological profiling of chalcones as antioxidant and anti-inflammatory activities
  14. Exosome as emerging therapeutic platform for wound healing: Current status, advancement and future crosstalk
  15. Oleosomes as emerging Next-Generation carrier for topical drug delivery
  16. Enzymatic and Nonenzymatic Mechanisms of ROS Generation in Metabolic Disorders
  17. The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties
  18. Assessment of Polyherbal Formulation for Hepatoprotective Activity in Carbon Tetrachloride-Induced Liver Toxicity
  19. Microbiota-brain interaction: The role of gut-derived proteins in addressing various neurological disorders including Parkinson’s (PD) and Alzheimer’s diseases (AD)
  20. A comprehensive review of the bioactive compounds and the various pharmacological activities of Mahua (Madhuca longifolia) plant
  21. Role of Mediterranean Diet in Alzheimer’s Disease: Pre-clinical and Clinical Evidence
  22. Evaluation of Suitability, Efficacy, and Safety of Zinc Hydroxide Adjuvant System Adsorbed on Tetanus Toxoid Vaccine
  23. Connection between Gut Microbiota and Neurodegenerative Diseases
  24. Design and development of N-Heterocyclic protease inhibitors for flaviviral infections: a synthetic and SAR-based review
  25. Revolutionizing vaccination: the marvel of nanovaccination technology
  26. Targeting tryparedoxin-dependent peroxidase (TXNPx) enzyme to identify repurposing drug candidates from FDA-approved drugs and natural products using virtual screening, ADME/Tox and MD simulations
  27. Application of Machine Learning (ML) approach in discovery of novel drug targets against Leishmania: A computational based approach
  28. Development and Assessment of Electrospun Nanofibrous Wound Dressing Containing Curcumin and Wedelolactone
  29. Advancement of artificial intelligence based treatment strategy in type 2 diabetes: A critical update
  30. Carica papaya in health and disease: a review of its bioactive compounds for treating various disease conditions, including anti-inflammatory and anti-arthritic activities
  31. A narrative review on the use of Green synthesized metallic nanoparticles for targeted cancer therapy
  32. Flavonoids and flavonoid-based nanoparticles for the treatment of arthritis
  33. Preparation and Evaluation of N-Acetyl D-Glucosamine Ethosomal Gel for the Treatment of Hyperpigmentation
  34. A critical review on SGLT2 inhibitors for diabetes mellitus, renal health, and cardiovascular conditions
  35. The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension Management: A critical Update
  36. Gut Microbiota and Postbiotic Metabolites: Biotic Intervention for Enhancing Vaccine Responses and Personalized Medicine for Disease Prevention
  37. A detailed examination of Coronavirus disease 2019 (COVID-19): covering past and future perspectives
  38. Gut microbiota modulation and health benefits of various fasting regimens
  39. Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System
  40. Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy
  41. Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach
  42. Safety Evaluation and antioxidant potential of new probiotic strain Bacillus subtilis (NMCC-path-14) in Balb/c mice by sub-acute repeated dose toxicity
  43. An Efficient Synthesis of Curcumin Pyrazole Analogues and their Biological Activities
  44. Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach
  45. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development
  46. Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
  47. Anti-Cancer and Anti-Diabetics Potentials of Punicalagin Derivatives Extracted from Peeled of Pomegranate (Punica granatum)
  48. Nanovesicles based drug targeting to control tumor growth and metastasis
  49. Retraction Note: Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
  50. Cadmium induced genotoxicity and antioxidative defense system in lentil (Lens culinaris Medik.) genotype
  51. High resolution cryo-EM structures of two potently SARS-CoV-2 neutralizing monoclonal antibodies of same donor origin that vary in neutralizing Omicron variants
  52. Physio-biochemical analysis and molecular characterization of induced lentil mutant lines
  53. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy
  54. Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management
  55. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review
  56. Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
  57. Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
  58. NEXT GENERATION SEQUENCE ANALYSIS OF SEQUENCES FROM SRA FILE OF HIV-1 ENVELOPE PROTEIN.
  59. Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with inhibitors
  60. Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host
  61. Synthesis, Cytotoxic Evaluation, and Molecular Docking Studies of New Oxadiazole Analogues
  62. Computational elucidation, mutational and hot spot-based designing of potential inhibitors against human acid-sensing ion channels (hASIC-1a) to treat various physiological conditions
  63. Recent advancement and treatment of leishmaniasis based on pharmacoinformatics approach: Current and future outlook
  64. In silico identification of novel antagonists and binding insights by structural and functional analyses of guanylate kinase of Leishmania donovani and interaction with inhibitors
  65. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis
  66. Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
  67. Glucose-6-phosphate dehydrogenase and Trypanothione reductase interaction protects Leishmania donovani from metalloid mediated oxidative stress
  68. In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance
  69. Synthesis, Biological Evaluation and Molecular Docking Studies of Pyridine Incorporated Chalcone Derivatives as Anticancer Agents
  70. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development
  71. Computational Elucidation of Structural Basis for Ligand Binding with Mycobacterium tuberculosis Glucose-1-Phosphate Thymidylyltransferase (RmlA)
  72. Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole analogues as anticancer agents
  73. In vitro studies of the antileishmanial activity of the newer 2-(substitutedphenoxy)-N-[(aryl)methylidene]acetohydrazide analogues
  74. Antileishmanial activity of sulfonamide compound
  75. Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b
  76. Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
  77. Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors
  78. Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase
  79. Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
  80. Computational elucidation of potential antigenic CTL epitopes in Ebola virus
  81. Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring
  82. Binding Pattern Elucidation of NNK and NNAL Cigarette Smoke Carcinogens with NER Pathway Enzymes: an Onco-Informatics Study
  83. Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials
  84. Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
  85. Computational Identification of microRNA-like Elements in Leishmania major
  86. Structure, evolution and virtual screening of NDM-1 strain from Kolkata
  87. Molecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura Virus
  88. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani
  89. Structure prediction of gBP21 protein ofL. donovaniand its molecular interaction
  90. Analysis of sequence, structure of GAPDH ofLeishmania donovaniand its interactions
  91. Computational Elucidation of Structural Basis for Ligand Binding with Leishmania donovani Adenosine Kinase
  92. Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP